Adult congenital heart disease: Toward prospective risk assessment of a multisystemic condition

Circulation

Volumn 117, Issue 18, 2008, Pages 2311-2312

  Khairy, Paul ^a,b   Landzberg, Michael J ^b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Editorials; Heart defects, congenital; Kidney; Prognosis

Indexed keywords

CAPTOPRIL; DIURETIC AGENT; URIC ACID;

ACUTE HEART INFARCTION; CARDIOVASCULAR RISK; COMORBIDITY; CONGENITAL HEART DISEASE; CYANOSIS; CYANOTIC HEART DISEASE; DEMOGRAPHY; DISEASE ASSOCIATION; EDITORIAL; GLOMERULUS FILTRATION RATE; GLUCOSE INTOLERANCE; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE FUNCTION; HUMAN; HYPOGLYCEMIA; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

ADULT; HEART DEFECTS, CONGENITAL; HUMANS; RISK ASSESSMENT;

EID: 43649090688     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.770594     Document Type: Editorial

References (10)

1. Perloff JK. Systemic complications of cyanosis in adults with congenital heart disease: hematologic derangements, renal function, and urate metabolism. Cardiol Clin. 1993;11:689-699.
2. Khairy P, Fernandes SM, Mayer JE Jr, Triedman JK, Walsh EP, Lock JE, Landzberg MJ. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117:85-92.
3. Davos CH, Davlouros PA, Wensel R, Francis D, Davies LC, Kilner PJ, Coats AJ, Piepoli M, Gatzoulis MA. Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot. Circulation. 2002;106(suppl I):I-69-I-75.
4. Dimopoulos K, Diller G-P, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, Salukhe TV, Piepoli MF, Poole-Wilson PA, Best N, Francis DP, Gatzoulis MA. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117:2320-2328.
5. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol. 1999;150:327-333.
6. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
7. Luellen JK, Shadish WR, Clark MH. Propensity scores: an introduction and experimental test. Eval Rev. 2005;29:530-558.
8. Morabia A. On the origin of Hill's causal criteria. Epidemiology. 1991;2:367-369.
9. Tokmakova MP, Skali H, Kenchaiah S, Braunwald E, Rouleau JL, Packer M, Chertow GM, Moye LA, Pfeffer MA, Solomon SD. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study. Circulation. 2004;110:3667-3673.
10. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285-1295.